Journal of Clinical Endocrinology & Metabolism, Vol 58, 458-462, Copyright © 1984 by Endocrine Society

ARTICLES

Serotonergic stimulation of adrenocorticotropin secretion in man

DA Lewis and BM Sherman

Controversy still exists regarding the role of serotonin in the regulation of ACTH secretion. We gave normal men three oral doses (0.5, 1.0, and 1.5 mg/kg) of fenfluramine, a serotonin-releasing agent and uptake inhibitor, and a corresponding placebo. There was a significant dose-dependent stimulatory effect of fenfluramine on both ACTH and cortisol levels. After the highest dose of fenfluramine, mean ACTH and cortisol levels increased from 20.8 pg/ml and 7.3 micrograms/dl to 35.5 pg/ml and 15.1 micrograms/dl, respectively. In a separate study, normal men were pretreated with cyproheptadine, a serotonin antagonist, before the administration of fenfluramine. Cyproheptadine did not significantly alter basal ACTH or cortisol levels, but it did blunt the responses of both hormones to fenfluramine. Cyproheptadine pretreatment did not alter plasma levels of fenfluramine. These findings support a stimulatory role for serotonin in the regulation of ACTH secretion in man.

This article has been cited by other articles:

				P. Osei-Owusu, A. James, J. Crane, and K. E. Scrogin 5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1324 - 1330. [Abstract] [Full Text] [PDF]

				A. J. Bond, S. Feizollah, and M. H. Lader The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function J Psychopharmacol, January 1, 1995; 9(1): 1 - 8. [Abstract] [PDF]